77 related articles for article (PubMed ID: 19450556)
21. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.
Fujimoto Y; Salam KA; Furuta A; Matsuda Y; Fujita O; Tani H; Ikeda M; Kato N; Sakamoto N; Maekawa S; Enomoto N; de Voogd NJ; Nakakoshi M; Tsubuki M; Sekiguchi Y; Tsuneda S; Akimitsu N; Noda N; Yamashita A; Tanaka J; Moriishi K
PLoS One; 2012; 7(11):e48685. PubMed ID: 23144928
[TBL] [Abstract][Full Text] [Related]
23. Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease.
Slater MJ; Amphlett EM; Andrews DM; Bamborough P; Carey SJ; Johnson MR; Jones PS; Mills G; Parry NR; Somers DO; Stewart AJ; Skarzynski T
Org Lett; 2003 Nov; 5(24):4627-30. PubMed ID: 14627400
[TBL] [Abstract][Full Text] [Related]
24. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
[TBL] [Abstract][Full Text] [Related]
25. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of hepatitis C virus NS3/4A: alpha-ketoamide based macrocyclic inhibitors.
Avolio S; Robertson K; Hernando JI; DiMuzio J; Summa V
Bioorg Med Chem Lett; 2009 Apr; 19(8):2295-8. PubMed ID: 19285390
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.
Li X; Zhang YK; Liu Y; Zhang S; Ding CZ; Zhou Y; Plattner JJ; Baker SJ; Liu L; Bu W; Kazmierski WM; Wright LL; Smith GK; Jarvest RL; Duan M; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Ni ZJ; Zou W; Wright J
Bioorg Med Chem Lett; 2010 Dec; 20(24):7493-7. PubMed ID: 21041080
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
[TBL] [Abstract][Full Text] [Related]
29. Psammaplin A inhibits hepatitis C virus NS3 helicase.
Salam KA; Furuta A; Noda N; Tsuneda S; Sekiguchi Y; Yamashita A; Moriishi K; Nakakoshi M; Tsubuki M; Tani H; Tanaka J; Akimitsu N
J Nat Med; 2013 Oct; 67(4):765-72. PubMed ID: 23359228
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
32. Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
Chaudhuri R; Lee H; Truong L; Torres J; Patel K; Johnson ME
J Chem Inf Model; 2012 Aug; 52(8):2245-56. PubMed ID: 22697413
[TBL] [Abstract][Full Text] [Related]
33. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
34. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
[TBL] [Abstract][Full Text] [Related]
35. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.
Reddy BU; Mullick R; Kumar A; Sharma G; Bag P; Roy CL; Sudha G; Tandon H; Dave P; Shukla A; Srinivasan P; Nandhitha M; Srinivasan N; Das S
Antiviral Res; 2018 Feb; 150():47-59. PubMed ID: 29224736
[TBL] [Abstract][Full Text] [Related]
36. Let-7b is a novel regulator of hepatitis C virus replication.
Cheng JC; Yeh YJ; Tseng CP; Hsu SD; Chang YL; Sakamoto N; Huang HD
Cell Mol Life Sci; 2012 Aug; 69(15):2621-33. PubMed ID: 22391672
[TBL] [Abstract][Full Text] [Related]
37. Humanized-VHH transbodies that inhibit HCV protease and replication.
Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
[TBL] [Abstract][Full Text] [Related]
38. Small molecule inhibitors of HCV replication from pomegranate.
Reddy BU; Mullick R; Kumar A; Sudha G; Srinivasan N; Das S
Sci Rep; 2014 Jun; 4():5411. PubMed ID: 24958333
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia.
Yamashita A; Salam KA; Furuta A; Matsuda Y; Fujita O; Tani H; Fujita Y; Fujimoto Y; Ikeda M; Kato N; Sakamoto N; Maekawa S; Enomoto N; Nakakoshi M; Tsubuki M; Sekiguchi Y; Tsuneda S; Akimitsu N; Noda N; Tanaka J; Moriishi K
Mar Drugs; 2012 Apr; 10(4):744-761. PubMed ID: 22690141
[TBL] [Abstract][Full Text] [Related]
40. Identification of a lead like inhibitor of the hepatitis C virus non-structural NS2 autoprotease.
Shaw J; Harris M; Fishwick CW
Antiviral Res; 2015 Dec; 124():54-60. PubMed ID: 26518228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]